PGI3 IMPACT OF DOSE ESCALATION ON TREATMENT COST OF IMMUNOBIOLOGICAL THERAPIES FOR CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

Autor: Fioratti, C., Rachid, M.L., Baida, R., Decimoni, T., Brunelli, M.J.
Zdroj: In Value in Health Regional Issues October 2019 19 Supplement:S34-S35
Databáze: ScienceDirect